A Canadian Federal Court decision (July 9, 2018) is a victory not only for Dr. Peter Doshi who filed a suit to gain access to pharmaceutical data, against the Attorney General of Canada; it is a victory for “open access” and affirmation . . . Continue reading →
FDA documents obtained under the Freedom of Information Act, revealed that the FDA has been concealing from the medical community and the public serious research misconduct; including fraud, deception, avoidable risks for human subjects — even deaths — that occurred in clinical . . . Continue reading →
1967-1968: Grünenthal executives were put on trial in Aachen, Germany The indictment charged the company with intent to commit bodily harm and involuntary manslaughter. The central defendant was Dr. Heinrich Mückter, an indicted Nazi war criminal, who was the company’s chief scientist . . . Continue reading →
Part I. America’s commercially profitable healthcare system is wasteful, inefficient and exceedingly harmful. Medical interventions are the third Leading cause of death.
Since 1995 FDA scientists have been at odds against FDA managers who routinely override sientists’ safety concerns to approve dubious prescription drugs. Continue reading →
Autism: Vaccine Injury Compensation Program (VICP) data. Continue reading →
"For patients, navigating the debate can be difficult because doctors, patient advocacy groups and manufacturers often endorse positions that are in their economic self-interest." The New York Times Continue reading →
Since 2006, the results of a multi-site clinical trial (MIST) that tested a surgical device have been at the center of dispute among cardiologists on both sides of the Atlantic. Continue reading →
Using drugs to cope with battlefield traumas is not discussed much outside the Army, but inside the service it has been the subject of debate for years.
Continue reading →
Antidepressant Makers Withhold Data on Children – Washington Post Thu, 29 Jan 2004 A front page article in The Washington Post addresses the key issue undermining public health and safety. Drug companies conceal unfavorable clinical trial findings: the tests failed to demonstrate . . . Continue reading →
Bad Medicine – Editorial – Guardian UK Sat, 12 Jun 2004 New York State Attorney General, Eliot Spitzer, is being recognized as a hero on both sides of the Atlantic. That’s because, unlike FDA officials, he knows how to use a “smoking . . . Continue reading →
FDA Is Flexing Less Muscle where Safety is the Issue – Wash Post Thu, 18 Nov 2004 The Washington Post examines FDA’s record of surveillance and the evidence is clear: since 1992 when Congress required drug companies to pay users fees to . . . Continue reading →
